Kessler Topaz Meltzer & Check, LLP: Investigation on Behalf of LifeStance Health Group, Inc. Shareholders
Kessler Topaz Meltzer & Check, LLP is currently investigating potential violations of the federal securities laws on behalf of purchhasers of LifeStance Health Group, Inc. (NASDAQ: LFST) (“LifeStance”) securities between June 9, 2021 and August 11, 2021.
LifeStance investors may receive additional information about the investigation by clicking the link "Submit Your Information" above.
LifeStance is one of the nation’s largest providers of virtual and in-person outpatient mental health care for children, adolescents and adults experiencing a variety of mental health conditions.
On August 11, 2021, LifeStance announced financial results for the second quarter ended June 30, 2021. The company reported a $70 million net loss in the second quarter and issued third quarter guidance that missed estimates as healthcare companies struggle to retain physicians suffering burnout by the COVID-19 pandemic.
Following this news, LifeStance’s stock price was down over 47% in early morning trading on August 12, 2021.
If you have any questions or would like to discuss this investigation, please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq. (484) 270-1453; toll-free at (844) 887-9500; or via e-mail at [email protected].
Please complete this form relating to your transactions for LifeStance Health Group, Inc. (NASDAQ: LFST) securities between June 9, 2021 and August 11, 2021.
You may also contact James Maro, Esq. (484) 270-1453; or toll free at (844) 887-9500; or you may submit your information via email at [email protected]; or you may click here to print a PDF of this form.